Takeda, a prominent global biopharmaceutical leader driven by research and development, maintains a significant presence in the United States, embodying a commitment to its 240-year-old history and Japanese heritage in all endeavors. With an unwavering dedication to prioritizing patient welfare, Takeda's scientific pursuits aim to address unmet medical needs, guided by a principle of patient-centricity.
Integral to Takeda's global enterprise, its U.S. operations play a pivotal role in advancing health outcomes and fostering a brighter future worldwide. Massachusetts serves as a central hub for several key global business functions, encompassing the U.S. Commercial Business Unit, Global Research and Development, Global Oncology, Global Vaccines, Biologics Manufacturing, and Cell Therapy Manufacturing.
Beyond Massachusetts, Takeda maintains major operations across five additional states, boasting research and manufacturing facilities, as well as a network of plasma donation centers spanning the nation. These facilities and centers support Takeda's groundbreaking work in rare and plasma-derived therapeutic areas, bolstered by an extensive field network dedicated to enhancing healthcare accessibility and innovation.